Delivery Order SPE2DB24D2018-SPE2DB25FWSS3

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price delivery order, valued at $14,981.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a $1,317.41 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine doses, with a period of performance through May 2, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This is a $46,466.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a $2,251.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567137242 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines and has a completion date of February 4, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a $2,134.98 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, which is a vaccine product. The delivery order is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, that enables DLA to efficiently procure a comprehensive range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine. The contract has a firm fixed price of $12,228.74 and an ultimate completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary...
This is a delivery order valued at $3,079.35 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This is a $2,663.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a type of vaccine, with a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $3,939.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,549,323 units of the Typhim VI 25 mcg/0.5 mL vaccine. The contract has an ultimate completion date of August 23, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
This is a $74,904.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565179811 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWSS3
    Delivery Order

This is a $2,759.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine and is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC enables the government to procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, syringes, and other critical medical commodities to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/30/25, 10:26 AM